GAO Criticizes FDA on How it Handles Drugs

The Government Accountability Office has published a report sharply critical of the Food and Drug Administration.  The report states that the organization is sometimes too slow in recognizing safety problems once drugs have gone to market.  The GAO report also says the FDA does not have clear policies for addressing drug safety issues and that it sometimes excludes its best safety experts from important meetings.